Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Savara Inc
(NQ:
SVRA
)
3.600
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Savara Inc
< Previous
1
2
3
4
5
Next >
Savara to Present at the Jefferies Healthcare Conference
June 02, 2023
From
Savara Inc.
Via
Business Wire
Barnwell Industries And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
May 30, 2023
The Dow Jones closed higher by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Why Shares of Savara Jumped on Tuesday
May 16, 2023
The company released first-quarter earnings and said it had completed a phase 3 trial enrollment for its lead therapy.
Via
The Motley Fool
Savara Reports First Quarter Financial Results and Provides Business Update
May 15, 2023
From
Savara Inc.
Via
Business Wire
Why Shares of Savara Soared This Week
January 27, 2023
The clinical-stage biopharmaceutical company focuses on therapies to treat rare respiratory diseases.
Via
The Motley Fool
Savara Announces New Employment Inducement Grant
May 05, 2023
From
Savara Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
April 03, 2023
Via
Benzinga
Savara Announces New Employment Inducement Grant
March 31, 2023
From
Savara Inc.
Via
Business Wire
Savara Reports Fourth Quarter / Year-End 2022 Financial Results and Provides Business Update
March 30, 2023
From
Savara Inc.
Via
Business Wire
Savara to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 06, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
February 28, 2023
From
Savara Inc.
Via
Business Wire
JD.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
February 21, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Savara Announces New Leadership Appointments
February 14, 2023
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant
January 20, 2023
From
Savara Inc.
Via
Business Wire
$1.2 Million Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying
January 04, 2023
The Dow Jones edged lower on the first trading session of 2023. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
Savara Announces New Employment Inducement Grant
November 22, 2022
From
Savara Inc.
Via
Business Wire
Savara Reports Third Quarter 2022 Financial Results and Provides Business Update
November 10, 2022
From
Savara Inc.
Via
Business Wire
Savara to Participate in Three Upcoming Investor Conferences
November 09, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
September 14, 2022
From
Savara Inc.
Via
Business Wire
Savara Presented Data at the European Respiratory Society (ERS) International Congress 2022
September 06, 2022
From
Savara Inc.
Via
Business Wire
Savara to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 01, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces Resignation of Chief Medical Officer
August 26, 2022
From
Savara Inc.
Via
Business Wire
Savara Awarded Promising Innovative Medicine (PIM) Designation in the United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
August 25, 2022
From
Savara Inc.
Via
Business Wire
Recap: Savara Q2 Earnings
August 11, 2022
Savara (NASDAQ:SVRA) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Savara reported in-line EPS of...
Via
Benzinga
Savara Reports Second Quarter 2022 Financial Results and Provides Business Update
August 11, 2022
From
Savara Inc.
Via
Business Wire
Savara Announces Acceptance of Three Abstracts at the European Respiratory Society (ERS) International Congress 2022
July 11, 2022
From
Savara Inc.
Via
Business Wire
Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic
June 16, 2022
From
Savara Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
June 13, 2022
Gainers
Via
Benzinga
Savara to Present at Jefferies Healthcare Conference
June 01, 2022
From
Savara Inc.
Via
Business Wire
Savara to Present at H.C. Wainwright Global Investment Conference
May 17, 2022
From
Savara Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.